AVDL logo

Avadel Pharmaceuticals plc (AVDL) Free Cash Flow

Annual FCF:

-$46.91M+$81.60M(+63.50%)
December 31, 2024

Summary

  • As of today (October 8, 2025), AVDL annual free cash flow is -$46.91 million, with the most recent change of +$81.60 million (+63.50%) on December 31, 2024.
  • During the last 3 years, AVDL annual free cash flow has risen by +$30.43 million (+39.35%).
  • AVDL annual free cash flow is now -156.74% below its all-time high of $82.66 million, reached on December 31, 2015.

Performance

AVDL Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Quarterly FCF:

$12.68M+$20.91M(+254.05%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL quarterly free cash flow is $12.68 million, with the most recent change of +$20.91 million (+254.05%) on June 1, 2025.
  • Over the past year, AVDL quarterly free cash flow has increased by +$30.68 million (+170.47%).
  • AVDL quarterly free cash flow is now -49.36% below its all-time high of $25.04 million, reached on March 31, 2015.

Performance

AVDL Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

TTM FCF:

$5.89M+$30.68M(+123.77%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL TTM free cash flow is $5.89 million, with the most recent change of +$30.68 million (+123.77%) on June 1, 2025.
  • Over the past year, AVDL TTM free cash flow has increased by +$118.67 million (+105.22%).
  • AVDL TTM free cash flow is now -83.48% below its all-time high of $35.67 million, reached on June 30, 2017.

Performance

AVDL TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

AVDL Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+63.5%+170.5%+105.2%
3Y3 Years+39.4%+172.3%+106.3%
5Y5 Years-22.3%+263.1%+115.1%

AVDL Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+63.5%at high+133.0%at high+104.5%
5Y5-Year-22.3%+63.5%at high+133.0%at high+104.5%
All-TimeAll-Time-156.7%+63.5%-49.4%+122.1%-83.5%+104.5%

AVDL Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$12.68M(+254.0%)
$5.89M(+123.8%)
Mar 2025
-
-$8.23M(-190.5%)
-$24.78M(+46.4%)
Dec 2024
-$46.91M(+63.5%)
$9.10M(+218.8%)
-$46.26M(+43.6%)
Sep 2024
-
-$7.65M(+57.5%)
-$81.98M(+27.3%)
Jun 2024
-
-$17.99M(+39.4%)
-$112.78M(+14.3%)
Mar 2024
-
-$29.70M(-11.6%)
-$131.64M(+0.4%)
Dec 2023
-$128.51M(-81.0%)
-$26.62M(+30.8%)
-$132.17M(-8.2%)
Sep 2023
-
-$38.45M(-4.3%)
-$122.17M(-37.1%)
Jun 2023
-
-$36.86M(-21.9%)
-$89.10M(-27.7%)
Mar 2023
-
-$30.23M(-81.8%)
-$69.78M(+5.2%)
Dec 2022
-$71.02M(+8.2%)
-$16.63M(-208.9%)
-$73.59M(+5.4%)
Sep 2022
-
-$5.38M(+69.3%)
-$77.80M(+16.1%)
Jun 2022
-
-$17.53M(+48.5%)
-$92.76M(-8.6%)
Mar 2022
-
-$34.05M(-63.4%)
-$85.39M(-14.2%)
Dec 2021
-$77.34M(-58.4%)
-$20.84M(-2.5%)
-$74.79M(-0.9%)
Sep 2021
-
-$20.34M(-100.0%)
-$74.15M(-13.6%)
Jun 2021
-
-$10.17M(+56.6%)
-$65.26M(-3.8%)
Mar 2021
-
-$23.44M(-16.0%)
-$62.87M(-23.1%)
Dec 2020
-$48.83M(-27.3%)
-$20.20M(-76.3%)
-$51.07M(-30.8%)
Sep 2020
-
-$11.46M(-47.3%)
-$39.05M(-12.3%)
Jun 2020
-
-$7.78M(+33.2%)
-$34.79M(-22.8%)
Mar 2020
-
-$11.64M(-42.2%)
-$28.34M(+25.3%)
Dec 2019
-$38.35M(+62.7%)
-$8.18M(-13.8%)
-$37.94M(+28.2%)
Sep 2019
-
-$7.19M(-441.1%)
-$52.84M(+18.6%)
Jun 2019
-
-$1.33M(+93.7%)
-$64.93M(+36.8%)
Mar 2019
-
-$21.24M(+8.0%)
-$102.71M(-3.2%)
Dec 2018
-$102.89M(-177.8%)
-$23.09M(-19.7%)
-$99.52M(-8.7%)
Sep 2018
-
-$19.28M(+50.7%)
-$91.53M(+29.4%)
Jun 2018
-
-$39.11M(-116.7%)
-$129.59M(-58.6%)
Mar 2018
-
-$18.05M(-19.5%)
-$81.69M(-111.3%)
Dec 2017
-$37.04M(-309.3%)
-$15.10M(+73.7%)
-$38.66M(-134.2%)
Sep 2017
-
-$57.33M(-751.9%)
-$16.51M(-146.3%)
Jun 2017
-
$8.80M(-64.8%)
$35.67M(+59.9%)
Mar 2017
-
$24.97M(+254.0%)
$22.31M(+29.4%)
Dec 2016
$17.70M(-78.6%)
$7.06M(+236.9%)
$17.24M(+69.3%)
Sep 2016
-
-$5.15M(-12.8%)
$10.19M(-33.6%)
Jun 2016
-
-$4.57M(-122.9%)
$15.34M(-22.9%)
Mar 2016
-
$19.91M(-20.5%)
$19.91M(+22.8%)
Dec 2015
$82.66M(+769.6%)
-
-
Mar 2015
-
$25.04M(+523.2%)
$16.21M(+239.4%)
Dec 2014
-$12.35M
-$5.92M(-310.5%)
-$11.63M(+13.6%)
Sep 2014
-
$2.81M(+149.1%)
-$13.45M(+20.3%)
Jun 2014
-
-$5.72M(-104.7%)
-$16.88M(+0.9%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$2.80M(+63.9%)
-$17.03M(+23.5%)
Dec 2013
-$21.70M(+10.3%)
-$7.74M(-1169.2%)
-$22.26M(-53.4%)
Sep 2013
-
-$610.10K(+89.6%)
-$14.51M(-4.4%)
Jun 2013
-
-$5.88M(+26.7%)
-$13.90M(+15.6%)
Mar 2013
-
-$8.02M(+5.0%)
-$16.47M(+13.3%)
Dec 2012
-$24.21M(-98.0%)
-
-
Jun 2012
-
-$8.45M(-71.6%)
-$19.00M(-64.7%)
Mar 2012
-
-$4.92M(-37.9%)
-$11.53M(+2.6%)
Dec 2011
-$12.23M(-35.0%)
-$3.57M(-73.0%)
-$11.84M(-30.4%)
Sep 2011
-
-$2.06M(-110.2%)
-$9.08M(-29.4%)
Jun 2011
-
-$981.30K(+81.2%)
-$7.02M(-16.3%)
Mar 2011
-
-$5.23M(-548.8%)
-$6.04M(-648.8%)
Dec 2010
-$9.06M(-240.9%)
-$806.30K(+70.9%)
-$806.30K(+97.5%)
Dec 2009
$6.42M(+158.2%)
-
-
Dec 2008
-$11.03M(+63.8%)
-
-
Dec 2007
-$30.51M(+15.8%)
-$2.77M(+68.4%)
-$32.27M(-9.4%)
Sep 2007
-
-$8.77M(+12.8%)
-$29.50M(-42.3%)
Jun 2007
-
-$10.05M(+5.9%)
-$20.73M(+6.7%)
Mar 2007
-
-$10.68M(+7.5%)
-$22.23M(+47.0%)
Dec 2006
-$36.22M(-17.9%)
-
-
Jun 2006
-
-$11.55M(-4.1%)
-$41.92M(-22.6%)
Mar 2006
-
-$11.10M(+3.6%)
-$34.18M(-16.3%)
Dec 2005
-$30.71M(-70.8%)
-$11.50M(-48.0%)
-$29.39M(-43.4%)
Sep 2005
-
-$7.77M(-104.1%)
-$20.50M(+11.5%)
Jun 2005
-
-$3.81M(+39.5%)
-$23.15M(+1.0%)
Mar 2005
-
-$6.30M(-140.9%)
-$23.39M(-30.0%)
Dec 2004
-$17.99M(-308.3%)
-$2.61M(+74.9%)
-$17.99M(-1100.5%)
Sep 2004
-
-$10.43M(-157.4%)
-$1.50M(-116.8%)
Jun 2004
-
-$4.05M(-352.1%)
$8.93M(-0.4%)
Mar 2004
-
-$896.00K(-106.5%)
$8.96M(+3.8%)
Dec 2003
$8.63M(+17.7%)
$13.87M(>+9900.0%)
$8.63M(+264.8%)
Sep 2003
-
$0.00(+100.0%)
-$5.24M(0.0%)
Jun 2003
-
-$4.02M(-228.1%)
-$5.24M(-328.1%)
Mar 2003
-
-$1.22M(-53.0%)
-$1.22M(-53.0%)
Dec 2002
$7.34M(+285.2%)
-
-
Dec 2001
-$3.96M(+37.7%)
-
-
Dec 2000
-$6.36M(-29.5%)
-
-
Dec 1999
-$4.91M(+47.3%)
-
-
Dec 1998
-$9.32M(+11.2%)
-
-
Mar 1998
-
-$800.00K(-366.7%)
-$800.00K(-366.7%)
Dec 1997
-$10.50M(-84.2%)
-
-
Dec 1996
-$5.70M
-
-
Mar 1996
-
$300.00K
$300.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual free cash flow?
  • What is the all-time high annual free cash flow for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual free cash flow year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly free cash flow year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM free cash flow?
  • What is the all-time high TTM free cash flow for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM free cash flow year-on-year change?

What is Avadel Pharmaceuticals plc annual free cash flow?

The current annual free cash flow of AVDL is -$46.91M

What is the all-time high annual free cash flow for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual free cash flow is $82.66M

What is Avadel Pharmaceuticals plc annual free cash flow year-on-year change?

Over the past year, AVDL annual free cash flow has changed by +$81.60M (+63.50%)

What is Avadel Pharmaceuticals plc quarterly free cash flow?

The current quarterly free cash flow of AVDL is $12.68M

What is the all-time high quarterly free cash flow for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly free cash flow is $25.04M

What is Avadel Pharmaceuticals plc quarterly free cash flow year-on-year change?

Over the past year, AVDL quarterly free cash flow has changed by +$30.68M (+170.47%)

What is Avadel Pharmaceuticals plc TTM free cash flow?

The current TTM free cash flow of AVDL is $5.89M

What is the all-time high TTM free cash flow for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM free cash flow is $35.67M

What is Avadel Pharmaceuticals plc TTM free cash flow year-on-year change?

Over the past year, AVDL TTM free cash flow has changed by +$118.67M (+105.22%)
On this page